报告质量,效果大小和衰老干预措施的偏差:对DrugAge数据库的方法评估
Austin Parish1, John P A Ioannidis2, Kevin Zhang3
1Department of Emergency Medicine, Brookdale University Hospital Medical Center, Brooklyn, NY, USA. auparish@bhmcny.org.
npj aging
|November 27, 2025
概括
临床前的抗衰老研究表明报告和设计存在重大缺陷. 大多数非哺乳动物的发现并不转化为哺乳动物,这表明需要提高研究质量和方法.
科学领域:
- 老年学是一门学科.
- 临床前研究方法学
背景情况:
- 对减缓衰老的干预措施越来越感兴趣.
- 大多数抗衰老证据来源于动物研究.
- 临床前抗衰老研究质量和报告不足.
研究的目的:
- 系统地评估临床前抗衰老研究的质量和报告.
- 分析抗衰老干预措施中的偏差和效果大小.
- 评估发现的跨物种可翻译性.
主要方法:
- 对DrugAge数据库的分析.
- 包括667个临床前抗衰老研究.
- 评估报告质量,偏见和影响大小.
主要成果:
- 报告关键设计特征的重大缺陷,如随机化和盲目化.
- 报告质量和影响在不同物种之间存在很大差异.
- 只有三分之一的非哺乳动物发现转化为哺乳动物.
- 大多数研究都在生物体生命周期的很早开始进行干预.
结论:
- 在临床前的抗衰老研究中,有很大的改进空间.
- 需要在研究设计和报告中提高严格性.
- 对物种特异性影响和最佳干预时间的进一步调查是有必要的.
相关概念视频
Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Pharmacodynamics in Geriatric Patients: Effects of Age
172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
200
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
200
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
176
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
176
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
201
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
201
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
214
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
214


